☰

Timothy Schultz - Publications

Affiliations: 
2017 Drexel University, Philadelphia, PA, United States 
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Wang D, Schultz T, Novak GP, Baker S, Bennett DA, Narayan VA. Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 62: 855-865. PMID 29480187 DOI: 10.3233/Jad-170903  0.394
2015 Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T, Baek Y, Deerlin VV, Hu WT, Holtzman DM, Fagan AM, Perrin RJ, Grossman M, et al. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 339-348. PMID 26693175 DOI: 10.1016/J.Dadm.2015.06.008  0.374
2013 Samtani MN, Raghavan N, Shi Y, Novak G, Farnum M, Lobanov V, Schultz T, Yang E, DiBernardo A, Narayan VA. Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes. British Journal of Clinical Pharmacology. 75: 146-61. PMID 22534009 DOI: 10.1111/J.1365-2125.2012.04308.X  0.4
2013 Leung YY, Toledo J, Nefedov A, Polikar R, Raghavan N, Xie S, Farnum M, Schultz T, Baek Y, Lobanov V, DiBernardo A, Deerlin VV, Kling M, Chen-Plotkin A, Mailman M, et al. Identifying multi-analyte CSF biomarkers for Alzheimer’s disease in a multi-cohort study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.059  0.33
2013 Chen C, Hu Z, Milbank J, Schultz T. A visual analytic study of retracted articles in scientific literature Journal of the American Society For Information Science and Technology. 64: 234-253. DOI: 10.1002/Asi.22755  0.348
2012 Schultz T, Yang E, Farnum M, Lobanov V, Verbeeck R, Raghavan N, Samtani MN, Novak G, Shi Y, Narayan V, DiBernardo A. A novel subject synchronization clinical trial design for Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 31: 507-16. PMID 22614878 DOI: 10.3233/Jad-2012-120286  0.35
2012 Farnum M, Baek Y, Schultz T, Nefedov A, Xie S, Leung YY, Toledo J, Raghavan N, Chen-Plotkin A, Wolk D, Polikar R, DiBernardo A, Siderowf A, Davatzikos C, Van Deerlin V, et al. P1-006: An integrated approach to the development of biomarkers for Alzheimer's disease using hospital population data Alzheimer's & Dementia. 8: P109-P109. DOI: 10.1016/J.Jalz.2012.05.281  0.328
2012 Yang E, Farnum M, Lobanov V, Schultz T, Verbeeck R, Raghavan N, Samtani M, Narayan V, DiBernardo A. Framework for patient synchronization and its consequences for disease progression visualization and clinical trials Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1457  0.331
2012 Nefedov A, Toledo J, Leung YY, Raghavan N, Xie S, Polikar R, Farnum M, Schultz T, Baek Y, Lobanov V, DiBernardo A, Narayan V, Lee V, Arnold S, Trojanowski J, et al. P3-101: Neuropathological subtypes among subjects with Alzheimer's disease Alzheimer's & Dementia. 8: P488-P488. DOI: 10.1016/J.Jalz.2012.05.1321  0.357
2011 Yang E, Farnum M, Lobanov V, Schultz T, Verbeeck R, Raghavan N, Samtani MN, Novak G, Narayan V, DiBernardo A. Quantifying the pathophysiological timeline of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 26: 745-53. PMID 21694449 DOI: 10.3233/Jad-2011-110551  0.414
Show low-probability matches.